Ultrasound Guided Autologous Blood Injection in Temporomandibular Joint Dislocation

Launched by CAIRO UNIVERSITY · Feb 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat people who frequently experience temporomandibular joint (TMJ) dislocations. The researchers want to see if using ultrasound to guide a treatment called autologous blood injection (where a patient's own blood is injected) is more accurate and effective than a method that doesn’t use ultrasound. The goal is to help reduce the number of dislocation episodes and improve the overall treatment process.

To participate, you need to be at least 18 years old and have had at least three TMJ dislocations in the past six months that required medical help to fix. Other criteria include having a specific range of mouth opening and no serious health issues that could interfere with the study. If you join, you can expect to receive care from trained professionals, and your progress will be monitored throughout the study. It's important to know that some people may not be eligible due to certain health conditions, but if you meet the criteria, this could be a chance to explore a potentially helpful treatment for your TMJ dislocations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with at least 3 episodes of temporomandibular joint dislocation in the past 6 months.
• • Necessitating a visit to the emergency room or trained professional to reduce the dislocation.
• • Radiological evidence of displacement of condylar head beyond the articular eminence on wide mouth opening.
• • Maximum mouth opening (MMO) more than 40 mm.
• • Unilateral or bilateral.
• • Over 18 years of age.
• • Both gender Males or females.
• Exclusion Criteria:
• • Patient having inflammatory temporomandibular joint disease like tuberculous arthritis, rheumatoid arthritis.
• • Patients with bleeding disorders, pregnancy or bony pathology of temporomandibular joint .
• • Allergy to local anesthetic.
• • Severe epilepsy or Parkinson's disease.
• • Patient on anti-depressants or anti-psychotics.
• • Inability to follow-up the patient during the entire follow-up period.
• • Patients who had recent fracture at temporomandibular joint level or who had previous surgical interference to temporomandibular joint .
• • Refused to sign the written informed consent were also excluded.
• • Dystonia